Anti-Yo Positive Paraneoplastic Cerebellar Degeneration Associatedwith Ovarian Cancer: A Case Report and a Review of the Literature

Authors

  • Saher Baransi The Florence-Nightingale-Hospital, Department of Gynaecological Oncology, Duesseldorf, Germany. Translator
  • Verónica Luengas-Würzinger The Florence-Nightingale-Hospital, Department of Gynecological Oncology, Duesseldorf, Germany Author
  • Sabrina Classen-von Spee The Florence-Nightingale-Hospital, Department of Gynecological Oncology, Duesseldorf, Germany Author
  • Anca Dizdar The Florence-Nightingale-Hospital, Department of Gynecological Oncology, Duesseldorf, Germany Author
  • Friederike Rawert The Florence-Nightingale-Hospital, Department of Gynecological Oncology, Duesseldorf, Germany Author
  • Björn Lampe The Florence-Nightingale-Hospital, Department of Gynecological Oncology, Duesseldorf, Germany Author

Keywords:

PCD, Anti-Yo, Ovarian Cancer, Purkinje Cells, Neurological Symptoms

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a rare n eurological disorder in cancer patients, characterized by a widespread loss of Purkinje cells associated with a progressive pancerebellar dysfunction. Furthermore, PCD is characterized by acute or subacute onset of neurological symptoms such as cerebellar ataxia, dysarthria and nystagmus due to tumor-induced autoimmunity against cerebellar antigens. It is believed that anti-Yo occurs usually in women and is most likely associated with gynecologic or breast cancers. PCD often precedes the cancer diagnosis by months to years.  

Here, we present a case involving a 52-year-old woman who developed PCD symptoms two months before the diagnosis of ovarian cancer, which was associated with high levels of anti-Yo antibodies.  

Author Biography

  • Saher Baransi, The Florence-Nightingale-Hospital, Department of Gynaecological Oncology, Duesseldorf, Germany.

    Saher Baransi, The Florence-Nightingale-Hospital, Department of Gynaecological Oncology, Duesseldorf, Germany. 

Downloads

Published

2022-09-15